# Aglaia Oncology Funds

Aglaia Oncology Funds is a Private Equity based in Bilthoven, Netherlands.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Bilthoven, Netherlands
- **Region:** Europe
- **Address:** Bilthoven, Netherlands
- **Founded:** 2003
- **Assets under management:** Undisclosed
- **Website:** aglaia-oncology.com
- **LinkedIn:** https://www.linkedin.com/company/aglaia-biomedical-ventures

## Regulatory record

- **Reports private funds:** No

## About

Aglaia invests in oncology drug development companies and selects and matures early-stage breakthrough inventions with the potential to transform cancer treatment. The team has decades of experience in cancer research and oncology drug development. Since 2004, Aglaia has built a reputation starting up biotech companies focused on oncology drug development. Aglaia has invested in 12 early stage companies, of which 6 were founded by Aglaia, and brings hands-on experience designing R&D plans from early screening through clinical studies.

## Sectors

- Healthcare

## People

- Karl Rothweiler — Partner
- Folkert van Cleef — Partner
- Eric van der Putten — Partner
- Mark Krul — Partner
- Ernst Geutjes — Venture Partner

## Questions

### What stages does Aglaia Oncology Funds target?

The firm focuses on early stage, seed, start-up, and spin-off opportunities.

### Which sectors receive capital from Aglaia Oncology Funds?

Investments center on oncology and related life sciences areas.

### Does Aglaia Oncology Funds commit to external funds or direct deals?

Available information shows a venture strategy without specified fund or direct allocation split.

## Related profiles

- [Agista](https://altss.com/profile/agista)
- [AgLaunch](https://altss.com/profile/aglaunch)

---

Last updated: 2026-08-11T15:05:57.154Z

Canonical page: https://altss.com/profile/aglaia-oncology-funds

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology